Pila Pharma Danmark ApS: Financial statements 2020
CVR: 39023636
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Pila Pharma Danmark ApS (CVR 39023636) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,542,401 and a net result of DKK -2,805,709 compared with DKK -2,101,576 the year before. Equity in the 2020 report amounted to DKK 854,071. The solvency ratio was 81%.
- Gross Profit
- DKK -3,542,401
- Profit/Loss
- DKK -2,805,709
- Equity
- DKK 854,071
- Total Assets
- DKK 1,054,737
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -3.5M | -2.8M | 854K | 0 |
| 2019 | - | -2.4M | -2.1M | 909K | 1 |
Official annual report
How creditworthy is Pila Pharma Danmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Pila Pharma Danmark ApS has published its annual report for 2019. Gross profit came to DKK -2,366,859, and the net result was DKK -2,101,576.
About Pila Pharma Danmark ApS
Pila Pharma Danmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Dorte Xenia Gram. The company is owned by Pila Pharma AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,798,283 and a net result of DKK -3,780,896 compared with DKK -3,094,589 the year before. Equity in the 2025 report amounted to DKK 2,596,207.